Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future.

Kalra, Sanjay; Baruah, Manash P; Sahay, Rakesh K; Unnikrishnan, Ambika Gopalakrishnan; Uppal, Shweta; Adetunji, Omolara

Kalra, Sanjay; Baruah, Manash P; Sahay, Rakesh K; Unnikrishnan, Ambika Gopalakrishnan; Uppal, Shweta; Adetunji, Omolara.

Afiliación

Kalra S; Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India.
Baruah MP; Excel Care Hospitals, Guwahati, Assam, India.
Sahay RK; Department of Endocrinology, Osmania Medical College, Hyderabad, Telangana, India.
Unnikrishnan AG; Department of Endocrinology, Chellaram Diabetes Institute, Pune, Maharashtra, India.
Uppal S; Eli Lilly and Company (India) Pvt. Ltd., Gurgaon, Haryana, India.
Adetunji O; Eli Lilly and Company, Basingstoke, RG24 9NL, UK.

Indian J Endocrinol Metab ; 20(2): 254-67, 2016.

Article en En | MEDLINE | ID: mdl-27042424

Palabras clave

Beyond glycaemic control; comparison of glucagon-like peptide-1 receptor agonists; efficacy; glucagon-like peptide-1 receptor agonists; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Qualitative_research Idioma: En Revista: Indian J Endocrinol Metab Año: 2016 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google